(Q36414088)

English

Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Samar Masoumi-Moghaddam

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Afshin Amini

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Ai-Qun Wei

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Gregory Robertson

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

David L Morris

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

10 June 2015

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

29

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

28491-28501

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Possible use of CA-125 level normalization after the third chemotherapy cycle in deciding on chemotherapy regimen in patients with epithelial ovarian cancer: brief report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Ovarian cancer biomarkers for molecular biosensors and translational medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Vascular endothelial growth factor inhibition: conflicting roles in tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Angiogenesis in normal and neoplastic ovaries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Potential markers that complement expression of CA125 in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Pitfalls in the measurement of circulating vascular endothelial growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Basic fibroblast growth factor and receptor expression in human ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

30 September 2017

Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

28 June 2018

Vascular endothelial growth factor expression in ovarian serous carcinomas and its effect on tumor proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

28 June 2018

Vascular endothelial growth factor expression in early stage ovarian carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

28 June 2018

Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

27 July 2018

Prognostic importance of vascular endothelial growth factor-A expression and vascular endothelial growth factor polymorphisms in epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

21 September 2018

Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

21 September 2018

History of the FIGO cancer staging system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

21 September 2018

From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

21 September 2018

Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

21 September 2018

Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

21 September 2018

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

21 September 2018

Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

5 December 2018

Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherap

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4695074

5 December 2018

Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of basic fibroblast growth factor and its mRNA in advanced ovarian cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenic protein expression in advanced epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of aFGF and bFGF in ovarian cancer and their effect on ovarian cancer cell proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The effect of basic fibroblast growth factor in ovarian cancer growth and angiogenesis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markedly elevated levels of vascular endothelial growth factor in malignant ascites

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An experimental research in the inhibiting effect of bFGF-MAb on the growth of ovarian cancer cells and transplanted tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 125 and Vascular Endothelial Growth Factor in the Differential Diagnosis of Epithelial Ovarian Tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of CA 125 in advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of vascular endothelial growth factor in digestive neuroendocrine tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathology and classification of ovarian tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of intratumoral vascular endothelial growth factor as a marker of tumour angiogenesis in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26143638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.18632/ONCOTARGET.4427

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36414088&oldid=1630055123"